Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00953043 · ClinicalTrials.gov registry record · Phase 4
Lubiprostone, Colonic Motility and Sensation
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00953043: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT00953043 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00953043, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study is being done to evaluate the effects of lubiprostone, a drug approved and used for constipation, on pattern of contractions of the colon and the colon's sensitivity to distension.
Interventions
- DRUG Placebo
- DRUG lubiprostone
- OTHER Bowel preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00953043
The ClinicalTrials.gov registry entry for NCT00953043 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00953043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00953043 about?
NCT00953043 is a clinical study titled "Lubiprostone, Colonic Motility and Sensation". This study is being done to evaluate the effects of lubiprostone, a drug approved and used for constipation, on pattern of contractions of the colon and the colon's sensitivity to distension.
What is the current status of trial NCT00953043?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-09. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00953043?
The interventions under investigation include: Placebo (DRUG), lubiprostone (DRUG), Bowel preparation (OTHER).
Who is sponsoring clinical trial NCT00953043?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.